Alterity Therapeutics Ltd
ATHE· Nasdaq
Who holds Alterity Therapeutics Ltd, from the managers’ Form 13F reports for the quarter ended Sep 30, 2026.
Form 13F covers managers with $100 million or more. Positions are as of the quarter end and filed up to 45 days later; the latest quarter fills in as reports land.
| Manager | Shares | Change | Value | Of portfolio | Filed |
|---|---|---|---|---|---|
| Pinnacle Financial Group, Inc. | 75.4K | — | $275.4K | 0.1% | Nov 16, 2026 |
| Greenleaf Trust | 62K | ±0% | $226.3K | 0.1% | Oct 29, 2026 |
| HB Wealth Management, LLC | 58.5K | ±0% | $213.4K | 0.1% | Oct 23, 2026 |
| Morgan Stanley | 57.2K | −9.2% | $208.9K | 0% | Nov 13, 2026 |
| BNP Paribas Financial Markets | 15.3K | +49.9% | $56K | 0% | Nov 12, 2026 |
| XTX Topco Ltd | 11.8K | New | $42.8K | 0.1% | Nov 16, 2026 |
| Rhumbline Advisers | 2K | ±0% | $7.3K | 0% | Nov 10, 2026 |
| GAMMA Investing LLC | 1.4K | −38.2% | $5.2K | 0.1% | Oct 8, 2026 |
| Farther Finance Advisors, LLC | 236 | +505.1% | $858 | 0% | Oct 8, 2026 |
| Wells Fargo & Company | 100 | New | $365 | 0% | Nov 16, 2026 |
| Osaic Holdings, Inc. | 68 | ±0% | $246 | 0% | Nov 12, 2026 |
| Tower Research Capital LLC (TRC) | 49 | New | $179 | 0% | Nov 16, 2026 |
| Citigroup Inc | 43 | +4,200.0% | $156 | 0% | Nov 4, 2026 |
| Blue Trust, Inc. | 40 | ±0% | $146 | 0% | Oct 15, 2026 |
| CoreCap Advisors, LLC | 21 | ±0% | $77 | 0% | Oct 8, 2026 |
| Steward Partners Investment Advisory, LLC | 6 | ±0% | $22 | 0% | Nov 13, 2026 |
| JPMorgan Chase & Co | 5 | New | $18 | 0% | Nov 12, 2026 |
| Nisa Investment Advisors, LLC | 3 | New | $11 | 0% | Oct 20, 2026 |
| Acadian Asset Management LLC | 1.9K | ±0% | $6 | 0% | Nov 9, 2026 |
| Caitong International Asset Management Co., Ltd | 1 | ±0% | $4 | 0% | Oct 29, 2026 |
| Cranbrook Wealth Management, LLC | 1 | ±0% | $4 | 0% | Oct 28, 2026 |
| Danske Bank A/S | 1 | ±0% | $4 | 0% | Nov 9, 2026 |